BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 6, 2021
View Archived Issues
Enrollment ongoing in phase I/II study of PVSRIPO
Read More
Mersana starts phase I/II umbrella study of XMT-1536 in high-grade serous ovarian cancer
Read More
Venadaparib shows safety and preliminary efficacy in first-in-human trial
Read More
Novel tau tubulin kinase 1 inhibitors reduce tau phosphorylation in vivo
Read More
Vaccinia virus-expressed SARS-CoV-2 spike protein promotes cellular and humoral immunity in mice
Read More
Antitumor activity of luxeptinib described in phase Ia/b study in B-cell malignancies
Read More
BCMA CAR-T cells engineered with membrane-bound IL-15 show increased in vivo activity
Read More
Dose-dependent weight loss seen in first-in-human study of LY-3437943
Read More
Model of diastolic dysfunction with preserved ejection fraction developed to test HDAC6 inhibition
Read More
Phase I data for CC-90001 in healthy subjects and in participants with hepatic impairment
Read More
Roche patents new BRAF inhibitors
Read More
Chinese investigators divulge P2X3 receptor antagonists
Read More
Shenzhen Jingtai Technology presents Ret inhibitors
Read More
Vivavision Biotechnology describes new ROCK2 inhibitors
Read More
PTC Therapeutics discloses compounds for familial dysautonomia
Read More
SYNB-1934, optimized live bacterial therapeutic for the treatment of phenylketonuria
Read More
Bio-ADM, a novel biomarker of congestion in acute dyspnea
Read More
Phase II FORCE study of avdoralimab in COVID-19 misses primary endpoints
Read More
Phase I/II trial explores Gadeta's gamma delta TCR cell therapy GDT-002 for multiple myeloma
Read More
Downregulation of ERBB4 leads to peripartum cardiomyopathy
Read More
HUTCHMED initiates phase I study of HMPL-295 in advanced solid tumors
Read More
HIV rebound biomarkers give insights into controllers and, unexpectedly, comorbidities
Read More
BNC-210 advances into phase IIb trial in PTSD
Read More